BRIEF-Incyte - Announces Agreement With CMS To Resolve Opzelura Medicaid Rebate Litigation - SEC Filing

Incyte Corporation

Incyte Corporation

INCY

0.00

June 22 (Reuters) - Incyte Corp INCY.O:

  • INCYTE - ANNOUNCES AGREEMENT WITH CMS TO RESOLVE OPZELURA MEDICAID REBATE LITIGATION - SEC FILING

  • INCYTE - CMS WILL NOT APPLY LINE EXTENSION REGULATION TO OPZELURA; INCYTE WITHDRAWS LAWSUIT - SEC FILING

  • INCYTE - EXPECTS ONE-TIME NON-CASH BENEFIT OF $246 MILLION IN Q2 ENDING JUNE 30, 2026 - SEC FILING

  • INCYTE - WILL NO LONGER ACCRUE FOR LINE EXTENSION REGULATIONS FOR OPZELURA; EXPECTS GROSS-TO-NET IMPROVEMENT - SEC FILING

  • INCYTE - PLANS TO UPDATE FINANCIAL GUIDANCE TO REFLECT SETTLEMENT IMPACT AT NEXT EARNINGS RELEASE - SEC FILING

  • INCYTE: SETTLEMENT WAS REACHED BASED ON THE UNIQUE FACTS OF OPZELURA AND JAKAFI

Source text: [ID:n0000879169-26-000046]

Further company coverage: INCY.O


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.